Activity of faropenem with and without rifampicin against Mycobacterium tuberculosis: evaluation in a whole-blood bactericidal activity trial

β-Lactams against Tuberculosis — New Trick for an Old Dog?

(2016) Andreas H. Diacon et al.   NEW ENGLAND JOURNAL OF MEDICINE

Repurposing clinically approved cephalosporins for tuberculosis therapy

(2016) Santiago Ramón-García et al.   Scientific Reports

Carbapenems and Rifampin Exhibit Synergy against Mycobacterium tuberculosis and Mycobacterium abscessus

(2015) Amit Kaushik et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Mycobactericidal Activity of Sutezolid (PNU-100480) in Sputum (EBA) and Blood (WBA) of Patients with Pulmonary Tuberculosis

(2014) Robert S. Wallis et al.   PLoS One

Meropenem-Clavulanic Acid Shows Activity against Mycobacterium tuberculosis In Vivo

(2012) Kathleen England et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Rapid Evaluation in Whole Blood Culture of Regimens for XDR-TB Containing PNU-100480 (Sutezolid), TMC207, PA-824, SQ109, and Pyrazinamide

(2012) Robert S. Wallis et al.   PLoS One

Pharmacokinetics and Whole‐Blood Bactericidal Activity againstMycobacterium tuberculosisof Single Doses of PNU‐100480 in Healthy Volunteers

(2010) Robert S. Wallis et al.   JOURNAL OF INFECTIOUS DISEASES

Lipiarmycin targets RNA polymerase and has good activity against multidrug-resistant strains of Mycobacterium tuberculosis

(2008) M. Kurabachew et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

The early bactericidal activity of anti-tuberculosis drugs: a literature review

(2008) P.R. Donald et al.   TUBERCULOSIS

Faropenem Medoxomil

(2007) Jacob P Gettig et al.   ANNALS OF PHARMACOTHERAPY